Anaesthetic induction for caesarean section with etomidate compared with thiopentone

Area of Science:

• Obstetric Anesthesia
• Pharmacology

Background:

• Cesarean section anesthesia requires a balance between maternal narcosis and neonatal well-being.
• Thiopentone is currently considered the safest induction agent, but no ideal agent exists.

Purpose of the Study:

• To evaluate etomidate as an induction agent for elective cesarean section anesthesia.
• To compare the neonatal outcomes and maternal-fetal acid-base balance between etomidate and thiopentone.

Main Methods:

• A prospective study comparing etomidate (0.3 mg/kg) with a historical thiopentone (3.5 mg/kg) group for elective cesarean sections.
• Neonatal assessment included alertness and time to sustained respiration.
• Maternal-to-fetal base excess gradients were measured.

Main Results:

• Infants in the etomidate group were more alert and achieved sustained respiration faster than those in the thiopentone group.
• Narrower maternal-to-fetal base excess gradients were observed with etomidate.
• Etomidate demonstrated a favorable safety profile in this obstetric anesthesia context.

Conclusions:

• Etomidate may provide advantages over thiopentone for anesthetic induction in elective cesarean sections.
• Further clinical trials are warranted to confirm the safety and efficacy of etomidate in obstetric anesthesia.